Vera Gielen, PhD

Bepirovirsen Value Evidence Leader
GSK (at time of study), United Kingdom

Poster(s):

• (257) Economic Burden of Liver Progression in Patients with Chronic Hepatitis B Virus Infection in the United States
  Wednesday, October 29, 2025